GB610570A - Antibiotics - Google Patents

Antibiotics

Info

Publication number
GB610570A
GB610570A GB10144/46A GB1014446A GB610570A GB 610570 A GB610570 A GB 610570A GB 10144/46 A GB10144/46 A GB 10144/46A GB 1014446 A GB1014446 A GB 1014446A GB 610570 A GB610570 A GB 610570A
Authority
GB
United Kingdom
Prior art keywords
acid
centrifuged
aqueous
solids
extraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB10144/46A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of GB610570A publication Critical patent/GB610570A/en
Expired legal-status Critical Current

Links

Landscapes

  • Compounds Of Unknown Constitution (AREA)

Abstract

A streptomycin-like ether insoluble antibiotic substance is produced by subjecting the solids of a culture of Actinomyces griseus that has produced streptomycin to extraction with an aqueous acid, and, if desired, recovering the antibiotic substance in the extract. The extraction of the solids may be effected after or before their separation from the culture liquid, or at both stages. Thus the solids may first be separated, e.g. by centrifuging or filtration, and then extracted with an aqueous acid. Alternatively the whole culture, preferably after substantially maximum streptomycin production has been attained, may be acidified and the solid and liquid components intimately contacted, whereby the antibiotic substance in the solids is extracted into the streptomycin-containing liquid and enhances its activity. The residual solids from this latter process may, if desired, be subjected to a further treatment with an aqueous acid. The acid used may be inorganic or organic, sulphuric and citric acids being preferred, and the extraction may be effected at various pH values, e.g. 5.6 or 1.1, preferably between about 1 and 3, especially about 1.5-2. The time required for extraction decreases with rise in temperature, a short extraction (about 1/2 -3 hours) at a relatively high temperature (about 45 DEG -55 DEG C.) giving the best yields. In examples: (1) (a) an aqueous medium containing soya bean meal, dextrose, meat extract and sodium chloride is incubated with spores of A. griseus at 25 DEG C. and 10-15 lbs. pressure while stirring and passing a current of air; (b) the resulting culture is acidified to pH 3.5 with hydrochloric, agitated at 5 DEG C. and centrifuged, yielding a supernate of enhanced activity; (2) (a) the solid residue from (1) (b) is washed twice with distilled water and then extracted with N/10 hydrochloric acid adjusted to pH2 with sodium hydroxide, centrifuged and the process repeated, the two extracts being used as such (separately or mixed), or added to the liquid product of (1), or treated (together or separately) as follows: (b) the extract is neutralized and its active ingredient purified by adsorption on activated charcoal, elution with dilute hydrochloric acid at 70 DEG C., treatment of the eluate with phosphotungstic acid, decomposition of the precipitated phosphotungstate with barium hydroxide and, if desired, freeze-drying; further purification may be effected by reaction with picnic acid in aqueous solution, dissolving the picrate in acetone, passing the solution through an activated alumina chromatographic adsorption column, eluting the antibiotic-rich sections of the chromatogram with aqueous acetone and decomposing the eluate with sulphuric acid to obtain the sulphate of the antibiotic substance, which may be still further purified by reaction with a Reinecke salt, and decomposing the Reineckate with silver sulphate in aqueous solution; (3) (a) a medium as in (1) (a), but omitting the meat extract, is inoculated with spores and mycelium of A. griseus and similarly incubated; (b) a portion of the resulting culture is treated as in (1) (b) (at 4 DEG C.); (4) (a) the remainder of the product of (3) (a) is centrifuged and the sediment washed and then slurried with distilled water; (b) a portion of the slurry is adjusted to pH 2.08 with 5N hydrochloric acid, shaken at 24 DEG C. (the pH rising to 2.4) and then centrifuged; somewhat inferior results are obtained at pH 1.1-1.22, 3.1-3.9 or 5.0-5.4; (c) the sediment from (b) is again extracted with hydrochloric acid at pH 2.55 (or 5.62 or 1.88); (5) a further portion of the slurry of (4) (a) is adjusted to pH2 with 5N hydrochloric acid, stirred at 50 DEG C. and centrifuged; somewhat inferior results are obtained by longer extractions at 4 DEG C. or 37 DEG C.; (6) a further portion of the slurry of (4) (a) is adjusted to pH 2.15 with 5N sulphuric acid, stirred at 50 DEG C. and centrifuged; the sulphuric acid may be replaced by 40 per cent citric acid; (7) a medium as in (1) (a), except that the percentage of meat extract is halved, is incubated as in (3) (a), and the resulting culture is adjusted to pH 1.5 with 100 per cent sulphuric acid, agitated with the diatomaceous earth filter aid known by the Registered Trade Mark "Celite" and the activated charcoal known as "Nuchar," and centrifuged.
GB10144/46A 1945-04-05 1946-04-02 Antibiotics Expired GB610570A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US610570XA 1945-04-05 1945-04-05

Publications (1)

Publication Number Publication Date
GB610570A true GB610570A (en) 1948-10-18

Family

ID=22033349

Family Applications (1)

Application Number Title Priority Date Filing Date
GB10144/46A Expired GB610570A (en) 1945-04-05 1946-04-02 Antibiotics

Country Status (1)

Country Link
GB (1) GB610570A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003072564A1 (en) * 2002-02-27 2003-09-04 Cipla Ltd. Purification of citalopram
CN103645151A (en) * 2013-11-18 2014-03-19 宁夏泰瑞制药股份有限公司 Method used for rapid detection of spectinomycin content in spectinomycin broth or finished products

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003072564A1 (en) * 2002-02-27 2003-09-04 Cipla Ltd. Purification of citalopram
CN103645151A (en) * 2013-11-18 2014-03-19 宁夏泰瑞制药股份有限公司 Method used for rapid detection of spectinomycin content in spectinomycin broth or finished products
CN103645151B (en) * 2013-11-18 2016-06-15 宁夏泰瑞制药股份有限公司 A kind of method of spectinomycin content in quick mensuration spectinomycin fermented liquid or finished product

Similar Documents

Publication Publication Date Title
US2461922A (en) Antibiotic extraction from solids of actinomyces griseus culture
US4051314A (en) Polysaccharides and method for producing same
GB610570A (en) Antibiotics
US2631143A (en) Purification of antibiotics with water soluble salts of water insoluble carboxylic acids
US2595159A (en) Preparation of vitamin b12 concentrates from streptomyces griseus cultures
US2505053A (en) Method for recovering grisein
US2481267A (en) Lower aliphatic carboxylic acid salts of streptothricin and streptomycin
SU651656A3 (en) Method of joint obtaining of insulin and pancreatin
US2521770A (en) Selective carbon adsorption of impurities from acidic streptomycin solutions
SU508076A1 (en) Method for preparing carminomycin 1
US3185624A (en) Preparation of purified lipid a from crude lipid a derived from lipopolysaccharides of gram-negative bacteria
CN107686451B (en) Preparation method of chestnut skin extract containing ceramide
GB933828A (en) A process for preparing condiments
CN107789500B (en) Preparation method of coumarins in dendrobium candidum
US3262854A (en) Method for the recovery of heparin
SU971342A1 (en) Prolactin production method
US2664419A (en) Purification of antibiotics
Makarevich et al. Cardiac glycosides of Erysimum crepidifolium
JPH07147926A (en) Method for treating mushroom
US3911112A (en) Antibiotic substances and preparation
RU2176919C2 (en) Method of preparing preparations from vegetable medicinal raw
RU2186848C1 (en) Method of isolation of superoxide dismutase
US3326765A (en) Sparingly-soluble derivative of the kallikrein-inactivator and process for producingthe same
US2085768A (en) Method of separating and isolating the thyreotropic and the gonadotropic hormone of the anterior lobe of the hypophysis
US2557164A (en) Method of isolating quercitrin from peanut hulls